Added to this, the worldwide cold chain logistics spending is expected to reach $18.6 billion by 2022—up from $15billion in 2018.
These numbers indicate that cold chain logistics – pharma’s major component – need modernized systems that help preserve the quality of temperature-sensitive products.
Operational Challenges
Perishable, temperature-sensitive items are often very expensive to produce, limited in quantity, and need to reach their destinations in a specific time frame. In order to maintain their desired quality, these items are kept in safe environments, and within predefined temperature ranges. However, due to possible errors and gaps in monitoring and logistical problems, like an aircraft getting delayed on a hot tarmac, this is an area where pharma companies face the risk of very high cost product losses.
A failed cold chain poses a severe threat to patients by introducing the risk of delivery delays due to re-shipping products that have experienced environmental excursions. And at worst, by delivering unsafe products with undetected excursions. To ensure a seamless and efficient supply of products, it is essential to set up a robust system that delivers near-real-time insights and alerts across the end-to-end cold chain workflow.